Lisbon, Portugal
geral@cannabase.pt

Scientific Information about Cannabis

Database
Support Us
About

Date: 1990

Antianxiety effect of cannabidiol in the elevated plus-maze

Antianxiety effect of cannabidiol in the elevated plus-maze

admin
Comments Off on

Search:

Cannabinoids

ASP3652 CBD CBDV CBN Endocannabinoid HU-210 Other THC THCV Whole Plant

Symptoms

Anxiety Appetite & Weight Loss Bladder Dysfunction Dementia Dystonia Muscle Stiffness Nausea & Vomiting Neurodegeneration Pain Seizures Spasticity Tics

Diagnosis

ADHD Alcohol Consumption Alzheimer's Amyotrophic Lateral Sclerosis Anxiety Arthritis Asthma Autism Spectrum Disorder Brachial Plexus Avulsion Cancer Chemotherapy Chronic Pain Crohn's Disease Dementia Depression Epilepsy Fibromyalgia Functional Chest Pain generalized social anxiety disorder Glaucoma Headache Hepatitis C HIV HIV-1 Inflammatory Bowel Disease Intraocular Pressure Isaac's Syndrome Lennox-Gastaut Syndrome Lung Cancer Major Depressive Disorder Multiple Sclerosis Opioid Substitution Paraneoplastic Night Sweats Parkinson's Parkinson's Disease Postoperative Pain Psychosis PTSD Radiotherapy Schizophrenia Spinal Cord Injury Substitution Therapy Tourette's Traumatic Brain Injury Trichotillomania

Disorders

Blood Disorders Bones & Cartilage Disorders Cardiovascular Disorders Gastrointestinal Disorders Gynaecological Disorders Immune System Disorders Neurological Disorders Neuropsychiatric Disorders Oncological Disorders Respiratory System Disorders Skin & Tissue Disorders Sleep Disorders Substance Use Surgery Vision & Eyes Disorders

Study Type

Animal Trial Case-control Study Case Report Case Series Controlled Study Cross-sectional Study Crossover Trial Double-blind Exploratory Analyses Human Study Interventional Study in Vitro Study Longitudinal Analysis Meta-analysis Observational Study Open-label Trial Phase 1 Trial Phase 2 Trial Phase 3 Trial Placebo-controlled Prospective Cohort Study Prospective Study Randomised Trial Review Single-blind Survey Systematic Review

Clinical Trials Feed

Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics

27 June 2014

Study of Quetiapine Treatment for Cannabis Dependence

7 August 2009

Detection of Cannabis Impairment With an Eye Tracker

23 January 2019

Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence

14 March 2014

Combined Pharmacotherapy for Cannabis Dependency

25 November 2009

Behavioral Effects of Pregabalin and Cannabis

18 January 2012

Dronabinol Treatment for Marijuana Addiction

22 September 2005

Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1

18 August 2005

Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa

29 April 2019

Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia

21 September 2018

Pubmed Feed

Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and ...

Harnessing autophagy to overcome MEK-inhibitor induced resistance in metastatic melanoma.

Possible Interactions Between 5-HT2A Receptors and the Endocannabinoid System in Humans: Preliminary Evidence of Interactive Effects of Ayahuasca and ...

Vapes, e-cigs, and mods: what do young adults call e-cigarettes?

Cannabinoids for the treatment of cannabis abuse disorder.

Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse.

Cannabis and epilepsy.

Cannabis: Canada sees queues and shortages as it legalises recreational use.

Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects.

Resilience against marijuana use initiation in low-income African American youth.

Partners

Support Us

© 2019 dataCANNAbase Project